Skip to main content

Table 2 Comparison of various groups in terms of hemorrhagic complications

From: Thrombocytopenic patients with hematological malignancy who underwent fiberoptic bronchoscopy are they really under a significant hemorrhagic risk?

Variable

Hemorrhagic complication present

Hemorrhagic complication non-present

p value

Age

55 (47–58)

48 (18–67)

0.295

Febrile neutropenia duration (days)

8.5 (7–10)

11 (3–36)

0.381

Processing input platelet count (k/mm3)

51 (23–60)

46.60 (5–91.6)

0.920

PT value before intervention (second)

13 (13–31)

13 (9.7–24.7)

0.356

INR value before intervention

1.3 (1.3–2.6)

1.2 (0.8–2.08)

0.099

Blood urea value before intervention (mg/dl)

20 (18–59)

27 (5–110)

0.907